NO944959D0 - Dermatologisk middel, fremgangsmåte for fremstilling av dette, samt anvendelse derav - Google Patents

Dermatologisk middel, fremgangsmåte for fremstilling av dette, samt anvendelse derav

Info

Publication number
NO944959D0
NO944959D0 NO944959A NO944959A NO944959D0 NO 944959 D0 NO944959 D0 NO 944959D0 NO 944959 A NO944959 A NO 944959A NO 944959 A NO944959 A NO 944959A NO 944959 D0 NO944959 D0 NO 944959D0
Authority
NO
Norway
Prior art keywords
pct
oxygen
dermatological
skin
preparation
Prior art date
Application number
NO944959A
Other languages
English (en)
Other versions
NO306974B1 (no
NO944959L (no
Inventor
Udo Gross
Leonhard Zastrow
Joachim Roding
Klaus Stanzl
Original Assignee
Lancaster Group Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lancaster Group Ag filed Critical Lancaster Group Ag
Publication of NO944959D0 publication Critical patent/NO944959D0/no
Publication of NO944959L publication Critical patent/NO944959L/no
Publication of NO306974B1 publication Critical patent/NO306974B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO944959A 1992-06-26 1994-12-21 Dermatologisk middel, fremgangsmåte for fremstilling av dette, samt anvendelse derav NO306974B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4221268A DE4221268C2 (de) 1992-06-26 1992-06-26 Verwendung eines Dermatikums zur Unterstützung des Sauerstofftransportes in der Haut
PCT/DE1993/000572 WO1994000109A1 (de) 1992-06-26 1993-06-24 Dermatikum zur unterstützung des sauerstofftransportes in der haut

Publications (3)

Publication Number Publication Date
NO944959D0 true NO944959D0 (no) 1994-12-21
NO944959L NO944959L (no) 1994-12-21
NO306974B1 NO306974B1 (no) 2000-01-24

Family

ID=6462055

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944959A NO306974B1 (no) 1992-06-26 1994-12-21 Dermatologisk middel, fremgangsmåte for fremstilling av dette, samt anvendelse derav

Country Status (21)

Country Link
US (1) US5637318A (no)
EP (1) EP0647131B1 (no)
JP (1) JP3599112B2 (no)
AT (1) ATE131040T1 (no)
AU (1) AU668399B2 (no)
CA (1) CA2138974C (no)
CZ (1) CZ283657B6 (no)
DE (2) DE4221268C2 (no)
DK (1) DK0647131T3 (no)
ES (1) ES2083286T3 (no)
FI (1) FI110841B (no)
GR (1) GR3018338T3 (no)
HK (1) HK1002699A1 (no)
HU (2) HUT68947A (no)
IL (1) IL105945A (no)
NO (1) NO306974B1 (no)
NZ (1) NZ252999A (no)
PL (1) PL172326B1 (no)
SK (1) SK279824B6 (no)
WO (1) WO1994000109A1 (no)
ZA (1) ZA934571B (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0799017A1 (en) * 1994-11-15 1997-10-08 Osmotics Corporation Skin care compositions and methods
DE19715478A1 (de) * 1997-04-10 1998-10-15 Lancaster Group Gmbh Kosmetisches und dermatologisches Mittel auf Basis von hartmagnetischen Teilchen
DE19734547B4 (de) 1997-08-01 2004-08-19 Lancaster Group Gmbh Kosmetische Zusammensetzungen mit agglomerierten Substraten
DE19861012A1 (de) 1998-03-18 1999-09-30 Pharm Pur Gmbh Behandlungsmittel für die Ophthalmologie
US6302863B1 (en) 1998-06-16 2001-10-16 Nikolai Tankovich Method for removal of lipids via a perfluorocarbon tumescent solution
WO2000041671A2 (en) * 1999-01-12 2000-07-20 T & T Pharmaceuticals, Ltd. Composition, device, and method for subcutaneous fat removal
US6541447B1 (en) 1999-09-01 2003-04-01 B & M Healthcare Technologies, Inc. Wound healing composition and method for use thereof
DE10106288A1 (de) * 2001-02-02 2002-09-05 Coty Bv Revitalisierender Wirkkomplex für die Haut
US7357937B2 (en) * 2002-09-24 2008-04-15 Therox, Inc. Perfluorocarbon emulsions with non-fluorinated surfactants
CA2504329C (en) * 2002-11-01 2013-08-20 Biodelivery Sciences International, Inc. Geodate delivery vehicles
DE10257240B4 (de) * 2002-12-04 2005-03-10 Coty Bv Kosmetische Zusammensetzung mit elektrischen Ladungsträgern und deren Verwendung
DE10336841A1 (de) * 2003-08-11 2005-03-17 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Kosmetische Zusammensetzung zur Unterstützung des Sauerstofftransports in die Haut
DE10342449A1 (de) * 2003-09-13 2005-04-07 Beiersdorf Ag Verwendung von Sauerstoff in kosmetischen oder dermatologischen Zubereitungen
DE10358306B8 (de) * 2003-12-08 2005-03-03 Coty B.V. Kosmetisches und dermatologisches Sauerstoff-Trägersystem, Verfahren zu dessen Herstellung sowie seine Verwendung
DE102004039459B4 (de) 2004-08-10 2011-06-16 Lancaster Group Gmbh Kosmetischer Wirkstoffkomplex zur Hautregenerierung
DE102004039631A1 (de) 2004-08-11 2006-03-02 Lancaster Group Gmbh Pigmenthaltiges kosmetisches Mittel mit Anti-Alterungswirkung für die Haut
DE102004048987B3 (de) 2004-10-04 2005-12-15 Coty Deutschland Gmbh Kühlende kosmetische Zusammensetzung und deren Verwendung
DE102006008920B3 (de) 2006-02-21 2007-08-09 Lancaster Group Gmbh Kosmetisches Sonnenschutzprodukt auf Basis von W/Si-Emulsionen
CN101443272A (zh) * 2006-05-15 2009-05-27 弗吉尼亚联邦大学 用于受控和持续产生并输送过氧化物的方法和组合物
DE102006040450B3 (de) * 2006-08-24 2008-04-24 Coty Prestige Lancaster Group Gmbh Verwendung einer Zusammensetzung für die Hautbehandlung nach Röntgenbestrahlung
DE102006058394B3 (de) 2006-12-07 2008-06-26 Coty Prestige Lancaster Group Gmbh Hautbräunungs-Basisformulierung mit DHA
DE102007004916A1 (de) 2007-01-26 2008-07-31 Coty Prestige Lancaster Group Gmbh Antifalten-Kosmetikum auf Basis von Peptiden
DE102007010861B4 (de) 2007-03-01 2008-11-20 Coty Prestige Lancaster Group Gmbh Kosmetisches Lichtschutzmittel
DE102007024138A1 (de) 2007-05-23 2008-11-27 Coty Prestige Lancaster Group Gmbh Kosmetisches Hautreinigungsmittel
DE102008008473A1 (de) 2008-02-07 2009-08-13 Coty Prestige Lancaster Group Gmbh Hauttönungsmittel mit DHA auf Basis Wasser-Wachs-Öl
US20090202617A1 (en) * 2008-02-13 2009-08-13 Ward Kevin R Gas based wound and tissue therapeutics
DE102008014289A1 (de) 2008-03-11 2009-09-17 Coty Prestige Lancaster Group Gmbh Kosmetikum mit Anti-Alterungswirkung
SG10201608068SA (en) 2008-04-01 2016-11-29 Antipodean Pharmaceuticals Inc Compositions And Methods For Skin Care
FR2930727B1 (fr) * 2008-04-30 2012-10-05 Evolution Dermatologique Lab Composition pour le traitement des etats seborrheiques.
WO2010008594A1 (en) * 2008-07-18 2010-01-21 Oxygen Biotherapeutics, Inc. Method of treating traumatic brain injury
US20110229575A1 (en) * 2008-09-19 2011-09-22 Clauson Gary L Deep immersion flotation therapy for burn victims
US20100144597A1 (en) * 2008-12-10 2010-06-10 Ward Kevin R Novel combinatorial approaches to enhancing oxygen transport to tissues
EP2376633A1 (en) 2008-12-17 2011-10-19 AVI BioPharma, Inc. Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis
JP5674684B2 (ja) 2009-02-03 2015-02-25 マイクロビオン コーポレーション 上皮組織、急性および慢性創傷、細菌性バイオフィルムならびに他の適応症のための消毒剤としてのビスマス−チオール
CA2756685C (en) * 2009-04-15 2019-12-24 Oxygen Biotherapeutics, Inc. Emulsions of perfluorocarbons
DE102009026718A1 (de) 2009-06-04 2010-04-15 Henkel Ag & Co. Kgaa Hautbehandlung zur Porenverfeinerung II
US20140065209A1 (en) 2011-05-03 2014-03-06 Dupont Nutrition Biosciences Aps Probiotic bacteria for the topical treatment of skin disorders
CN107412001B (zh) 2011-08-16 2020-08-18 凯诗薇有限责任公司 使皮肤回春的组合物和方法
US10702558B2 (en) 2014-05-30 2020-07-07 Azitra Inc Therapeutic treatment of skin disease with recombinant commensal skin microorganisms
WO2017087640A1 (en) 2015-11-19 2017-05-26 Baum Marc M Probiotic treatment of skin diseases, disorders, and infections: formulations, methods and systems
KR20200021991A (ko) 2017-06-16 2020-03-02 아지트라 인코포레이티드 Lekti 발현 재조합 미생물을 사용하는 네테르톤 증후군의 치료를 위한 조성물 및 방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3049665T1 (de) * 1979-06-25 1982-03-18 Suntech Use of perfluorocarbon as burn treatment
US4569784A (en) * 1980-11-17 1986-02-11 Adamantech, Inc. Preparation of a gel having gas transporting capability
ATE18353T1 (de) * 1981-07-02 1986-03-15 Hoffmann La Roche Verfahren zur herstellung von liposomenloesungen.
GR78151B (no) * 1982-04-05 1984-09-26 Alcon Lab Inc
EP0105584B1 (en) * 1982-08-17 1989-01-18 Adamantech, Inc. Perfluorocarbon emulsions and their preparation and use in therapy
US5204112A (en) * 1986-06-16 1993-04-20 The Liposome Company, Inc. Induction of asymmetry in vesicles
AU2807689A (en) * 1986-09-19 1989-03-01 Chemex Pharmaceuticals Inc. Method for the treatment of body tissues and the administration of drugs thereto
US5219538A (en) * 1987-03-13 1993-06-15 Micro-Pak, Inc. Gas and oxygen carrying lipid vesicles
ES2030494T3 (es) * 1987-06-23 1992-11-01 Eniricerche S.P.A. Composicion de una fase conteniendo un aceite perfluorado y uno o varios agentes superficiactivos, util como excipiente para formulaciones cosmeticas y dermatologicas, asi como para aplicaciones biomedicinales.
US5160669A (en) * 1988-03-03 1992-11-03 Micro Vesicular Systems, Inc. Method of making oil filled paucilamellar lipid vesicles
US5061484A (en) * 1988-03-11 1991-10-29 Alpha Therapeutic Corporation Perfluorochemical emulsion with stabilized vesicles
WO1989008459A1 (en) * 1988-03-11 1989-09-21 Alpha Therapeutic Corporation Perfluorochemical emulsion with stabilized vesicles
WO1991000110A1 (en) * 1989-07-05 1991-01-10 Alliance Pharmaceutical Corp. Fluorocarbon emulsions having saturated phospholipid emulsifiers
US5091188A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
DE4127442C2 (de) * 1991-08-17 1996-08-22 Udo Dr Gros Wäßrige Dispersion Fluorcarbon enthaltender Phospholipid-Vesikel und ein Verfahren zu ihrer Herstellung
US5246703A (en) * 1991-12-27 1993-09-21 Dow Corning Corporation Siloxy-functional cyclopolysiloxanes

Also Published As

Publication number Publication date
CA2138974C (en) 2006-01-03
PL172326B1 (en) 1997-09-30
FI946056A (fi) 1994-12-23
GR3018338T3 (en) 1996-03-31
EP0647131B1 (de) 1995-12-06
DE4221268C2 (de) 1997-06-12
EP0647131A1 (de) 1995-04-12
ZA934571B (en) 1994-01-31
FI946056A0 (fi) 1994-12-23
IL105945A0 (en) 1993-10-20
DK0647131T3 (da) 1996-01-08
DE4221268A1 (de) 1994-01-05
ES2083286T3 (es) 1996-04-01
HUT68947A (en) 1995-08-28
JP3599112B2 (ja) 2004-12-08
CZ283657B6 (cs) 1998-05-13
SK279824B6 (sk) 1999-04-13
JPH07508006A (ja) 1995-09-07
NO306974B1 (no) 2000-01-24
CA2138974A1 (en) 1994-01-06
NO944959L (no) 1994-12-21
AU4307893A (en) 1994-01-24
AU668399B2 (en) 1996-05-02
HK1002699A1 (en) 1998-09-11
HU211273A9 (en) 1995-11-28
DE59301122D1 (de) 1996-01-18
FI110841B (fi) 2003-04-15
NZ252999A (en) 1997-06-24
ATE131040T1 (de) 1995-12-15
US5637318A (en) 1997-06-10
IL105945A (en) 1997-07-13
HU9403737D0 (en) 1995-02-28
WO1994000109A1 (de) 1994-01-06
CZ326694A3 (en) 1995-07-12
SK156794A3 (en) 1995-07-11

Similar Documents

Publication Publication Date Title
NO944959D0 (no) Dermatologisk middel, fremgangsmåte for fremstilling av dette, samt anvendelse derav
NO304294B1 (no) Kosmetisk preparat, fremgangsmÕte for fremstilling av dette, samt anvendelse derav
JP3561063B2 (ja) ベツリン酸を含む化粧品組成物
DE59301123D1 (de) Galenische zusammensetzung für die topische anwendung.
ZA9811926B (en) High glycerin containing anti-microbial cleansers.
DE59703511D1 (de) Kosmetikum bzw. kosmetikzusammensetzung zur glättung und straffung der haut bei gestörtem unterhaut-binde-fettgewebe, insbesondere bei der "cellulite"
ATE355058T1 (de) Verfahren zur behandlung von akne vulgaris mit einer avermectin-verbindung
DE69321974D1 (de) Lokal anwendbares präparat zur hemmung des haarwuchses
DE60116302D1 (de) Behandlung von seborrhoischer dermatitis
KR910021238A (ko) 켈로이드 치료제

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees